Misidentifying dementia may lead to higher costs, study finds

07/18/2013 | MedPage Today (free registration)

Medicare costs increased when patients with vascular or Parkinson's disease-related dementia were misdiagnosed with Alzheimer's disease, researchers said at the Alzheimer's Association International Conference. Dr. Ralph Nixon of NYU Langone Medical Center said the implications of a misdiagnosis include the missed opportunity for patients to get appropriate treatment.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC